P2RX5 and prostate carcinoma: P2XRs that are liganded/activated by ATP, such as P2X4, P2X5, and P2X7, are expressed at various stages of prostate cancer, including localized prostate cancer, HSPC, and metastatic castration-resistant prostate cancer (mCRPC) [33–35].